Frequency of Glucose Monitoring in Labor

Description

The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no protocols in place. The study will be a randomized controlled trial placing patients with Gestational Diabetes Mellitus (GDM) in "frequent" vs "infrequent" glucose monitoring intrapartum and assessing neonatal glucose levels at birth.

Conditions

Neonatal Hypoglycemia

Study Overview

Study Details

Study overview

The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no protocols in place. The study will be a randomized controlled trial placing patients with Gestational Diabetes Mellitus (GDM) in "frequent" vs "infrequent" glucose monitoring intrapartum and assessing neonatal glucose levels at birth.

Intrapartum Glucose Monitoring of GDM: A Randomized Controlled Trial

Frequency of Glucose Monitoring in Labor

Condition
Neonatal Hypoglycemia
Intervention / Treatment

-

Contacts and Locations

New York

Mount Sinai West Hospital, New York, New York, United States, 10019

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All female patients of reproductive age who have the diagnosis GDM
  • * Patient with singleton gestation presenting in labor or for induction
  • * Patients below the age of 18
  • * Multiple gestation pregnancy
  • * Patients undergoing scheduled c-section

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Thomas Owens, MD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

2024-11-26